Log in
Enquire now
‌

US Patent 11236071 Farnesoid X receptor agonists and uses thereof

Patent 11236071 was granted and assigned to Metacrine on February, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Metacrine
Metacrine
Current Assignee
Metacrine
Metacrine
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11236071
Date of Patent
February 1, 2022
Patent Application Number
16494272
Date Filed
March 14, 2018
Patent Citations
‌
US Patent 10377717 Farnesoid X receptor agonists and uses thereof
‌
US Patent 10626081 Farnesoid X receptor agonists and uses thereof
Patent Citations Received
‌
US Patent 11773094 Farnesoid X receptor agonists and uses thereof
Patent Primary Examiner
‌
D Margaret M Seaman
Patent abstract

Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11236071 Farnesoid X receptor agonists and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us